Administration of infliximab in Crohn's disease does not deplete complement components C3 and C4. [electronic resource]
Producer: 20010103Description: 3326-7 p. digitalISSN:- 0002-9270
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.